Clinical Trials Logo

Clinical Trial Summary

Attention deficit/hyperactivity disorder is a condition characterized by a decreased attention span, hyperactivity, and/or impulsiveness inappropriate for a certain age.

Typically, young children have what are known as subtle neurological signs. These are involuntary movements of one part of the body that occur while the child is making a voluntary movement of another part of the body. This is referred to as synkinesis, or overflow movements. These overflow movements disappear during normal development and are usually gone by the age of 10. However, in children with ADHD these overflow movements tend to be more intense and last long after the age of 10. This leads researchers to believe there is an abnormality in the maturation and development of the brain areas associated with motor activity in children with ADHD.

Transcranial Magnetic Stimulation (TMS) is a non-invasive technique that gives information about brain function. It is very useful when studying areas of the nervous system related to motor activity (motor cortex, corticospinal tract, and corpus callosum). A magnetic signal given from a special instrument held close to the patient's head stimulates a small area of the brain that controls a few muscles (for example, the muscles that control one finger). Doctors put electrodes (small pieces of metal taped to areas of the body) over the muscle to measure the electrical activity the muscle produces when it makes a movement. When the magnetic signal activates those muscles the electrodes pick up and record the electrical activity of the movement that the muscles make in response to the magnetic signal.

Researchers will study normal children and those diagnosed with ADHD using TMS to find out if the clinical abnormalities of ADHD are associated with a delay or abnormality in maturation of areas of the nervous system responsible for motor activity (motor cortex and corticospinal tract).


Clinical Trial Description

Subtle neurological signs (synkinesis and mirror movements) are present in normal children up until 9 or 10 years of age. In addition, speed of repetitive and sequential movements increases from 5 to 8 years of age at which time children perform these movements at close to adult speeds. Based on clinical studies of both normal children and of children with corticospinal tract lesions, it has been postulated that these subtle motor signs reflect neurodevelopmental immaturity of the intracortical and interhemispheric inhibitory systems and that their disappearance occurs as a result of maturation.

The presence of subtle neurological signs can accurately distinguish children with attention-deficit/hyperactivity disorder (ADHD) from healthy controls. The increased intensity of these neurological signs in younger age groups and their persistence beyond the age of 9 years suggest that children with ADHD may have delayed or abnormal neuromaturational development; in particular, development of the inhibitory systems of the motor cortex. This is in concert with the theories of cognitive abnormalities seen in these children where behavioral studies indicate that children with ADHD have most difficulty in executive function tests that look specifically at motor inhibition.

Transcranial magnetic stimulation (TMS) is a non-invasive tool which gives information about cortical function. It is particularly useful in the study of the motor cortex and its connections via the corticospinal tract and the corpus callosum. A single suprathreshold stimulus to the motor cortex produces a motor evoked potential (MEP) and inhibition of ongoing muscle activity in ipsilateral and contralateral target muscles. TMS studies have demonstrated differences in both the velocity of central motor conduction, and the ability to evoke motor inhibition when comparing adults with children under 10 years of age. These differences suggest that cortical inhibitory and facilitatory systems undergo normal developmental changes during the first decade of life, and that they may form the neural substrate for the clinical developmental changes that occur in children during this same period of time.

We propose to study children with ADHD with single and paired pulse TMS to determine if the clinical abnormalities present in these children reflect an underlying delay or abnormality in maturation of the inhibitory and facilitatory systems of the cortex and corticospinal tracts. If present, these findings would give objective evidence of abnormal inhibitory systems in attention-deficit/hyperactivity disorder; their presence (or absence) may differentiate between the different subtypes of ADHD. Since stimulants have an ameliorative effect on the neuropsychological functioning in these children, future studies would be able to determine whether they have a similar effect on the motor system.

TMS is associated with a click which can have a 120 dB peak sound level at maximum stimulator output. Studies in adults and children have shown no long-lasting or permanent hearing loss after TMS, but there is no information regarding transient decrease in hearing thresholds immediately after TMS as can occur after listening to music through headphones using personal cassette recorders. As part of the main study, we will be conducting a safety study to determine the risk for temporary hearing loss after TMS in children. ;


Study Design

N/A


Related Conditions & MeSH terms

  • Attention Deficit Disorder With Hyperactivity
  • Hyperkinesis

NCT number NCT00001915
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase N/A
Start date January 1999
Completion date February 2004

See also
  Status Clinical Trial Phase
Completed NCT00202605 - Safety and Efficacy of SPD465 in Adults With ADHD Phase 2
Not yet recruiting NCT02677519 - A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD Phase 4
Completed NCT02730572 - Concerta (Methylphenidate) -To-Generic Switch Study N/A
Completed NCT01681082 - Psychological Effects of Tai Chi Training N/A
Active, not recruiting NCT01330693 - Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy Phase 3
Completed NCT00830700 - Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study N/A
Completed NCT01012622 - An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) Phase 4
Completed NCT00626236 - Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems Phase 2
Completed NCT00598182 - Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study N/A
Completed NCT00381407 - Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT00178503 - Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children Phase 2/Phase 3
Completed NCT00247572 - Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories Phase 2
Completed NCT00118911 - Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder N/A
Completed NCT00218322 - Effectiveness of ATMX in Treating Adolescents With ADHD and SUD Phase 4
Completed NCT00557011 - NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD Phase 2
Completed NCT00071656 - Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I N/A
Active, not recruiting NCT00057668 - Preventing Behavior Problems in Children With ADHD Phase 2
Completed NCT00050622 - Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT00050050 - Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder Phase 1
Completed NCT00031395 - Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children Phase 3